|
| 36357160 | Consistency between trials presented at conferences, their subsequent publications and press releases. | BMJ Evid Based Med | 2023 |
| 37622312 | Payer-Negotiated Prices for Cardiac Electrophysiology Procedures at 2022-2023 Top 100 US News & World Report for Cardiology and Heart Surgery Hospitals. | Circ Arrhythm Electrophysiol | 2023 |
| 37589985 | Financial Conflicts of Interest in Public Comments on Medicare National Coverage Determinations of Medical Devices. | JAMA | 2023 |
| 37553403 | Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models. | Sci Data | 2023 |
| 37651145 | Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics. | JAMA Netw Open | 2023 |
| 37546792 | Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks. | medRxiv | 2023 |
| 37498597 | Association of Receipt of Paycheck Protection Program Loans With Staffing Patterns Among US Nursing Homes. | JAMA Netw Open | 2023 |
| 37603363 | Unique Device Identifiers-Missing in Action. | JAMA Intern Med | 2023 |
| 37603351 | Unique Device Identifiers for Medical Devices at 10 Years. | JAMA Intern Med | 2023 |
| 37603342 | Medical Product Industry Ties to Patient Advocacy Organizations' Executive Leadership. | JAMA Intern Med | 2023 |
| 37532876 | Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study. | J Gen Intern Med | 2023 |
| 37184854 | Availability of Unique Device Identifiers for Class I Medical Device Recalls From 2018 to 2022. | JAMA Intern Med | 2023 |
| 37017494 | Ensuring Public Trust in an Empowered FDA. | N Engl J Med | 2023 |
| 36977551 | Evidence of publication bias in multiple sclerosis clinical trials: a comparative analysis of published and unpublished studies registered in ClinicalTrials.gov. | J Neurol Neurosurg Psychiatry | 2023 |
| 36944478 | US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics. | BMJ Evid Based Med | 2023 |
| 37380503 | Longitudinal Patterns in Testosterone Prescribing After US FDA Safety Communication in 2014. | Jt Comm J Qual Patient Saf | 2023 |
| 37380118 | Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review. | J Clin Epidemiol | 2023 |
| 37042289 | Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020. | J Am Heart Assoc | 2023 |
| 37407074 | Therapeutic value of first versus supplemental indications of drugs in US and Europe (2011-20): retrospective cohort study. | BMJ | 2023 |
| 37438644 | The Changing Medical Publishing Industry: Economics, Expansion, and Equity. | J Gen Intern Med | 2023 |
| 37307009 | Approval of Drugs With Unmet Trial End Points-In Reply. | JAMA Intern Med | 2023 |
| 37037905 | Challenges and solutions to advancing health equity with medical devices. | Nat Biotechnol | 2023 |
| 37229515 | Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study. | Med Devices (Auckl) | 2023 |
| 37165687 | Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges. | Eur Heart J | 2023 |
| 37096328 | Pain Management in Older Adults Before and During the First Year of COVID-19 Pandemic: Prevalence, Trends, and Correlates. | J Gerontol A Biol Sci Med Sci | 2023 |
| 37358857 | US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019. | JAMA Netw Open | 2023 |
| 37294583 | Extending the US Food and Drug Administration's Postmarket Authorities. | JAMA Health Forum | 2023 |
| 37326989 | Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults. | JAMA Netw Open | 2023 |
| 36625810 | Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls. | JAMA | 2023 |
| 36521957 | Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study. | Lancet Glob Health | 2023 |
| 36623219 | Differences In Debt Among Postgraduate Medical Residents By Self-Designated Race And Ethnicity, 2014-19. | Health Aff (Millwood) | 2023 |
| 36443632 | Assessment of Market-Level Information on Quality Using Hospital Care Compare. | J Gen Intern Med | 2023 |
| 36780148 | US Food and Drug Administration Approval of Drugs Not Meeting Pivotal Trial Primary End Points, 2018-2021. | JAMA Intern Med | 2023 |
| 36690402 | Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. | BMJ Open | 2023 |
| 36936269 | Metrics, baseline scores, and a tool to improve sponsor performance on clinical trial diversity: retrospective cross sectional study. | BMJ Med | 2023 |
| 36738387 | Using real-world data from health systems to evaluate the safety and effectiveness of a catheter to treat ischemic ventricular tachycardia. | J Interv Card Electrophysiol | 2023 |
| 36732626 | Implementing clinical trial data sharing requires training a new generation of biomedical researchers. | Nat Med | 2023 |
| 36704544 | Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators. | BMJ Surg Interv Health Technol | 2023 |
| 36632328 | Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation. | JAMIA Open | 2023 |
| 36893934 | Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method. | Am Heart J | 2023 |
| 36793371 | Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018. | BMJ Surg Interv Health Technol | 2023 |
| 36631149 | Adding device identifiers to claims forms-a key step to advance medical device safety. | BMJ | 2023 |
| 36374487 | The Philips Respironics Recall of Ventilators and Positive Airway Pressure Machines-Breakdowns in Medical Device Surveillance. | JAMA Intern Med | 2023 |
| 36357730 | US Post-Graduate Residency Competitiveness, Trainee Diversity, and Future Salary Among 12 Clinical Specialties. | J Gen Intern Med | 2023 |
| 34505980 | Distribution of Paycheck Protection Program Loans to Healthcare Organizations in 2020. | J Gen Intern Med | 2022 |
| 35738713 | Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure. | J Am Coll Cardiol | 2022 |
| 35675195 | Medical Device User Fee Reauthorization - Back to Basics or Looking Ahead? | N Engl J Med | 2022 |
| 35438761 | FDA Indication Extrapolations-Allowing Flexibility While Providing Greater Clarity. | JAMA Netw Open | 2022 |
| 35435948 | Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance. | JAMA Intern Med | 2022 |
| 35577370 | Generating evidence during a pandemic: what's reliable? | BMJ | 2022 |